Cydectin TriclaMox 1mg/ml + 50 mg/ml Oral Solution for sheep

Land: Ierland

Taal: Engels

Bron: HPRA (Health Products Regulatory Authority)

Koop het nu

Productkenmerken Productkenmerken (SPC)
29-05-2023
DSU DSU (DSU)
30-01-2024

Werkstoffen:

Moxidectin; Triclabendazole

Beschikbaar vanaf:

Zoetis Belgium S.A.

ATC-code:

QP54AB52

INN (Algemene Internationale Benaming):

Moxidectin; Triclabendazole

Dosering:

1/50 milligram(s)/millilitre

farmaceutische vorm:

Oral solution

Prescription-type:

POM: Prescription Only Medicine as defined in relevant national legislation

Therapeutische categorie:

Sheep

Therapeutisch gebied:

moxidectin, combinations

therapeutische indicaties:

Endectoparasiticides

Autorisatie-status:

Authorised

Autorisatie datum:

2013-12-09

Productkenmerken

                                ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Cydectin TriclaMox 1 mg/ml + 50 mg/ml oral solution for sheep
Cydectin TriclaMox 1 mg/ml + 50 mg/ml orale Lösung für Schafe
(Austria, Germany)
Cydectine TriclaMox 1 mg/ml + 50 mg/ml solution orale pour ovins
(Belgium, France, Luxembourg)
Cydectin TriclaMox 1 mg/ml + 50 mg/ml Πόσιμο διάλυμα
για πρόβατα (Greece)
Cydectin TriclaMox 1 mg/ml + 50 mg/ml
mixtúra, lausn handa sauðfé (Iceland)
Cydectin TriclaMox 1 mg/ml + 50 mg/ml soluzione orale per pecore
(Italy)
Cydectin TriclaMox 1 mg/ml + 50 mg/ml oral solution for sheep
(Ireland, UK)
Cydectin TriclaMox 1 mg/ml + 50 mg/ml orale oplossing voor schapen
(The Netherlands)
Cydectin TriclaMox 1 mg/ml + 50 mg/ml solução oral para ovinos
(Portugal)
Cydectin TriclaMox 1 mg/ml + 50 mg/ml solución oral para ovino
(Spain)
TriclaMox vet. 1 mg/ml + 50 mg/ml, oral lösning till får (Sweden)
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCES:
Moxidectin
1.0 mg
Triclabendazole
50.0 mg
EXCIPIENTS:
QUALITATIVE
COMPOSITION OF EXCIPIENTS AND
OTHER CONSTITUENTS_ _
QUANTITATIVE
COMPOSITION
IF THAT INFORMATION IS
ESSENTIAL
FOR PROPER ADMINISTRATION OF THE
VETERINARY MEDICINAL PRODUC
t
_ _
Benzyl alcohol (E1519)
40.0 mg
Butylhydroxytoluene (E321)
1.0 mg
Polysorbate 80
_ _
Sorbitan oleate
Propylene glycol, dicaprylocaprate
A clear yellow to brown liquid.
3.
CLINICAL INFORMATION
3.1
TARGET SPECIES
Sheep.
3.2
INDICATIONS FOR USE FOR EACH TARGET SPECIES
For the treatment of mixed nematode and fluke infections, caused by
moxidectin and triclabendazole
sensitive strains of:
PARASITE
ADULT STAGE
L4
INHIBITED STAGES
NEMATODES
GASTRO-INTESTINAL NEMATODES:
_Haemonchus contortus_
•
•
•
_Teladorsagia circumcincta_
•
•
•
_Ostertagia trifurcata_
•
•
_Trichostrongylus axei_
•
•
•
_Trichostrongylus colubriformis_
•
•
_Trichostrongylus vitrinus_
•
•
_Nematodirus battus_
•
•
_Nematodirus spathiger_
•
•
_Nematodirus filicolis_

                                
                                Lees het volledige document
                                
                            

Zoekwaarschuwingen met betrekking tot dit product